Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6871 to 6885 of 7704 results

  1. Sintilimab with pemetrexed and platinum-based chemotherapy for untreated advanced non-squamous non-small-cell lung cancer [ID4050]

    Discontinued [GID-TA10934]

    Technology appraisal guidance
    Discontinued

  2. Intrapartum care for healthy women and babies - angle of episiotomy

    Discontinued [GID-NG10394]

    NICE guideline
    Discontinued

  3. Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

    Discontinued [GID-HST10019]

    Highly specialised technologies guidance
    Discontinued

  4. Nivolumab with ipilimumab for untreated PD-L1 positive unresectable or metastatic urothelial cancer [ID3829]

    Discontinued [GID-TA10707]

    Technology appraisal guidance
    Discontinued

  5. Ticagrelor for preventing stroke after previous ischaemic stroke or high-risk transient ischaemic attack [ID2689]

    Discontinued [GID-TA10663]

    Technology appraisal guidance
    Discontinued

  6. Terevalefim for treating delayed graft function after kidney transplant [ID1490]

    Discontinued [GID-TA11098]

    Technology appraisal guidance
    Discontinued

  7. Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID968]

    Discontinued [GID-TA10334]

    Technology appraisal guidance
    Discontinued

  8. Durvalumab with chemotherapy for untreated advanced non-small-cell lung cancer with no EGFR or ALK mutations [ID3751]

    Discontinued [GID-TA10616]

    Technology appraisal guidance
    Discontinued

  9. Surgical vessel sealing systems (MT798)

    In development [GID-MT594] Expected publication date: TBC

    Medical technologies guidance
    In development

  10. VTS-270 for treating Niemann-Pick type C1 [ID1267]

    In development [GID-HST10020] Expected publication date: TBC

    Highly specialised technologies guidance
    In development

  11. Nivolumab in combination for treating hormone-relapsed metastatic prostate cancer before chemotherapy [ID1619]

    Discontinued [GID-TA10490]

    Technology appraisal guidance
    Discontinued

  12. Haemochromatosis

    Discontinued [GID-NG10287]

    NICE guideline
    Discontinued

  13. Acute bowel obstruction

    Discontinued [GID-NG10377]

    NICE guideline
    Discontinued

  14. Endometriosis: diagnosis and management - surgical management - pain management post-surgery

    Discontinued [GID-NG10385]

    NICE guideline
    Discontinued

  15. Breathlessness

    Discontinued [GID-NG10387]

    NICE guideline
    Discontinued